Index by Author

January 1993; 42 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Alviggi, L

    • Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes January 1993 42:127-133; doi:10.2337/diabetes.42.1.127

  2. Anderson, L C

    • Tissue kallikrein and tonin levels in submandibular glands of STZ-induced diabetic rats and the effects of insulin. Diabetes January 1993 42:113-117; doi:10.2337/diabetes.42.1.113

B

  1. Bach, J F

    • Characterization of the extracellular matrix-containing giant perivascular spaces in the NOD mouse thymus. Diabetes January 1993 42:134-140; doi:10.2337/diabetes.42.1.134

  2. Beaulieu, C

    • Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes January 1993 42:35-43; doi:10.2337/diabetes.42.1.35

  3. Benecke, H

    • Muscle-specific expression of human insulin receptor in transgenic mice. Diabetes January 1993 42:206-212; doi:10.2337/diabetes.42.1.206

  4. Bliss, C R

    • Galanin-stimulated high-affinity GTPase activity in plasma membranes from RINm5F cells. Diabetes January 1993 42:74-79; doi:10.2337/diabetes.42.1.74

  5. Boden, G

    • Effects of ethanol on carbohydrate metabolism in the elderly. Diabetes January 1993 42:28-34; doi:10.2337/diabetes.42.1.28

  6. Bonadonna, R C

    • Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes January 1993 42:191-198; doi:10.2337/diabetes.42.1.191

  7. Bossoni, S

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  8. Boukobza-Vardi, N

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80

  9. Buscema, M

    • Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes January 1993 42:199-205; doi:10.2337/diabetes.42.1.199

C

  1. Caltabiano, V

    • Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes January 1993 42:199-205; doi:10.2337/diabetes.42.1.199

  2. Carnaud, C

    • Characterization of the extracellular matrix-containing giant perivascular spaces in the NOD mouse thymus. Diabetes January 1993 42:134-140; doi:10.2337/diabetes.42.1.134

  3. Chan, K M

    • Tissue kallikrein and tonin levels in submandibular glands of STZ-induced diabetic rats and the effects of insulin. Diabetes January 1993 42:113-117; doi:10.2337/diabetes.42.1.113

  4. Chao, J

    • Tissue kallikrein and tonin levels in submandibular glands of STZ-induced diabetic rats and the effects of insulin. Diabetes January 1993 42:113-117; doi:10.2337/diabetes.42.1.113

  5. Chen, D Z

    • Insulin secretory function in relation to transplanted islet mass in STZ-induced diabetic rats. Diabetes January 1993 42:98-105; doi:10.2337/diabetes.42.1.98

  6. Chen, X

    • Effects of ethanol on carbohydrate metabolism in the elderly. Diabetes January 1993 42:28-34; doi:10.2337/diabetes.42.1.28

  7. Christianson, S W

    • Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes January 1993 42:44-55; doi:10.2337/diabetes.42.1.44

  8. Cimino, A

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  9. Clark, P M

    • Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response. Diabetes January 1993 42:162-169; doi:10.2337/diabetes.42.1.162

  10. Cobelli, C

    • Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes January 1993 42:191-198; doi:10.2337/diabetes.42.1.191

  11. Colton, C K

    • Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes January 1993 42:12-21; doi:10.2337/diabetes.42.1.12

  12. Colwell, J A

    • Vascular thrombosis in type II diabetes mellitus. Diabetes January 1993 42:8-11

  13. Comini, M T

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  14. Cook, J T

    • Distribution of type II diabetes in nuclear families. Diabetes January 1993 42:106-112; doi:10.2337/diabetes.42.1.106

  15. Cotroneo, P

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

  16. Craven, P A

    • Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes January 1993 42:118-126; doi:10.2337/diabetes.42.1.118

D

  1. Danne, T

    • Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes January 1993 42:170-177; doi:10.2337/diabetes.42.1.170

  2. Dardenne, M

    • Characterization of the extracellular matrix-containing giant perivascular spaces in the NOD mouse thymus. Diabetes January 1993 42:134-140; doi:10.2337/diabetes.42.1.134

  3. Davidheiser, S

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80

  4. DeFronzo, R A

    • Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes January 1993 42:191-198; doi:10.2337/diabetes.42.1.191

  5. DeRubertis, F R

    • Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes January 1993 42:118-126; doi:10.2337/diabetes.42.1.118

  6. Desantis, R

    • Effects of ethanol on carbohydrate metabolism in the elderly. Diabetes January 1993 42:28-34; doi:10.2337/diabetes.42.1.28

  7. Dionne, K E

    • Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes January 1993 42:12-21; doi:10.2337/diabetes.42.1.12

  8. Dunlop, M

    • Fibronectin-induced increase in mesangial cell prostaglandin release. Effect of hyperglycemia and PKC inhibition. Diabetes January 1993 42:183-190; doi:10.2337/diabetes.42.1.183

F

  1. Feener, E P

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80

  2. Ferrannini, E

    • Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes January 1993 42:191-198; doi:10.2337/diabetes.42.1.191

  3. Finegood, D T

    • Insulin secretory function in relation to transplanted islet mass in STZ-induced diabetic rats. Diabetes January 1993 42:98-105; doi:10.2337/diabetes.42.1.98

  4. Flier, J S

    • Muscle-specific expression of human insulin receptor in transgenic mice. Diabetes January 1993 42:206-212; doi:10.2337/diabetes.42.1.206

  5. Forte, F

    • Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes January 1993 42:199-205; doi:10.2337/diabetes.42.1.199

G

  1. Garrett, J R

    • Tissue kallikrein and tonin levels in submandibular glands of STZ-induced diabetic rats and the effects of insulin. Diabetes January 1993 42:113-117; doi:10.2337/diabetes.42.1.113

  2. Gascon-Barré, M

    • Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes January 1993 42:35-43; doi:10.2337/diabetes.42.1.35

  3. Gazzoli, N

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  4. Ghirlanda, G

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

  5. Giustina, A

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  6. Giustina, G

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  7. Greco, A V

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

  8. Greene, D A

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

H

  1. Haffner, S M

    • Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes January 1993 42:154-161; doi:10.2337/diabetes.42.1.154

  2. Hales, C N

    • Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response. Diabetes January 1993 42:162-169; doi:10.2337/diabetes.42.1.162

  3. Hattersley, A T

    • Distribution of type II diabetes in nuclear families. Diabetes January 1993 42:106-112; doi:10.2337/diabetes.42.1.106

  4. Havrankova, J

    • Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes January 1993 42:35-43; doi:10.2337/diabetes.42.1.35

  5. Hazuda, H P

    • Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes January 1993 42:154-161; doi:10.2337/diabetes.42.1.154

  6. Higashi, S

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80

  7. Hiller, W F

    • The role of histocompatibility antigens in transplantation of isolated islets of Langerhans in the rat. Diabetes January 1993 42:90-97; doi:10.2337/diabetes.42.1.90

  8. Hockaday, T D

    • Distribution of type II diabetes in nuclear families. Diabetes January 1993 42:106-112; doi:10.2337/diabetes.42.1.106

  9. Hug, V

    • Nuclear protein-binding analysis of a GC-rich insulin-receptor promoter regulatory region. Diabetes January 1993 42:66-73; doi:10.2337/diabetes.42.1.66

  10. Hussain, M J

    • Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes January 1993 42:127-133; doi:10.2337/diabetes.42.1.127

I

  1. In't Veld, P A

    • Interaction of interleukin-1 with islet beta-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression. Diabetes January 1993 42:56-65; doi:10.2337/diabetes.42.1.56

J

  1. Jacobs, M C

    • Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes January 1993 42:148-153; doi:10.2337/diabetes.42.1.148

K

  1. Kaiser, N

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80

  2. Kapma, J A

    • Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes January 1993 42:148-153; doi:10.2337/diabetes.42.1.148

  3. Keogh, R

    • Fibronectin-induced increase in mesangial cell prostaglandin release. Effect of hyperglycemia and PKC inhibition. Diabetes January 1993 42:183-190; doi:10.2337/diabetes.42.1.183

  4. Kestekian, R

    • Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes January 1993 42:35-43; doi:10.2337/diabetes.42.1.35

  5. King, G L

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80

  6. Klein, H H

    • Muscle-specific expression of human insulin receptor in transgenic mice. Diabetes January 1993 42:206-212; doi:10.2337/diabetes.42.1.206

  7. Klempnauer, J

    • The role of histocompatibility antigens in transplantation of isolated islets of Langerhans in the rat. Diabetes January 1993 42:90-97; doi:10.2337/diabetes.42.1.90

L

  1. Larkins, R G

    • Fibronectin-induced increase in mesangial cell prostaglandin release. Effect of hyperglycemia and PKC inhibition. Diabetes January 1993 42:183-190; doi:10.2337/diabetes.42.1.183

  2. Leahy, J L

    • Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic rats. Diabetes January 1993 42:22-27; doi:10.2337/diabetes.42.1.22

  3. Leiter, E H

    • Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes January 1993 42:44-55; doi:10.2337/diabetes.42.1.44

  4. Leproux, G B

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  5. Leslie, R D

    • Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes January 1993 42:127-133; doi:10.2337/diabetes.42.1.127

  6. Levy, J C

    • Distribution of type II diabetes in nuclear families. Diabetes January 1993 42:106-112; doi:10.2337/diabetes.42.1.106
    • Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response. Diabetes January 1993 42:162-169; doi:10.2337/diabetes.42.1.162

  7. Levy, J R

    • Nuclear protein-binding analysis of a GC-rich insulin-receptor promoter regulatory region. Diabetes January 1993 42:66-73; doi:10.2337/diabetes.42.1.66

  8. Lewis, J T

    • Insulin secretory function in relation to transplanted islet mass in STZ-induced diabetic rats. Diabetes January 1993 42:98-105; doi:10.2337/diabetes.42.1.98

  9. Ling, Z

    • Interaction of interleukin-1 with islet beta-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression. Diabetes January 1993 42:56-65; doi:10.2337/diabetes.42.1.56

  10. Luan, J J

    • Characterization of the extracellular matrix-containing giant perivascular spaces in the NOD mouse thymus. Diabetes January 1993 42:134-140; doi:10.2337/diabetes.42.1.134

  11. Lutterman, J

    • Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes January 1993 42:148-153; doi:10.2337/diabetes.42.1.148

M

  1. Magnani, P

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

  2. Manto, A

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

  3. Menzinger, G

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

  4. Mitchell, B D

    • Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes January 1993 42:154-161; doi:10.2337/diabetes.42.1.154

  5. Moller, D E

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80
    • Muscle-specific expression of human insulin receptor in transgenic mice. Diabetes January 1993 42:206-212; doi:10.2337/diabetes.42.1.206

  6. Morales, P A

    • Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes January 1993 42:154-161; doi:10.2337/diabetes.42.1.154

  7. Mozzoli, M

    • Effects of ethanol on carbohydrate metabolism in the elderly. Diabetes January 1993 42:28-34; doi:10.2337/diabetes.42.1.28

N

  1. Nordt, T K

    • Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes January 1993 42:1-7; doi:10.2337/diabetes.42.1.1

P

  1. Patel, P

    • Distribution of type II diabetes in nuclear families. Diabetes January 1993 42:106-112; doi:10.2337/diabetes.42.1.106

  2. Peakman, M

    • Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes January 1993 42:127-133; doi:10.2337/diabetes.42.1.127

  3. Pipeleers, D G

    • Interaction of interleukin-1 with islet beta-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression. Diabetes January 1993 42:56-65; doi:10.2337/diabetes.42.1.56

  4. Proctor, G B

    • Tissue kallikrein and tonin levels in submandibular glands of STZ-induced diabetic rats and the effects of insulin. Diabetes January 1993 42:113-117; doi:10.2337/diabetes.42.1.113

  5. Przybylski, R J

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80

  6. Purrello, F

    • Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes January 1993 42:199-205; doi:10.2337/diabetes.42.1.199

R

  1. Rabuazzo, A M

    • Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes January 1993 42:199-205; doi:10.2337/diabetes.42.1.199

  2. Romanelli, G

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  3. Rosenthal, N

    • Muscle-specific expression of human insulin receptor in transgenic mice. Diabetes January 1993 42:206-212; doi:10.2337/diabetes.42.1.206

S

  1. Saccomani, M P

    • Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes January 1993 42:191-198; doi:10.2337/diabetes.42.1.191

  2. Sasson, S

    • Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes January 1993 42:80-89; doi:10.2337/diabetes.42.1.80

  3. Savino, W

    • Characterization of the extracellular matrix-containing giant perivascular spaces in the NOD mouse thymus. Diabetes January 1993 42:134-140; doi:10.2337/diabetes.42.1.134

  4. Schneider, D J

    • Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes January 1993 42:1-7; doi:10.2337/diabetes.42.1.1

  5. Seely, L

    • Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes January 1993 42:191-198; doi:10.2337/diabetes.42.1.191

  6. Sharp, G W

    • Galanin-stimulated high-affinity GTPase activity in plasma membranes from RINm5F cells. Diabetes January 1993 42:74-79; doi:10.2337/diabetes.42.1.74

  7. Shori, D K

    • Tissue kallikrein and tonin levels in submandibular glands of STZ-induced diabetic rats and the effects of insulin. Diabetes January 1993 42:113-117; doi:10.2337/diabetes.42.1.113

  8. Shultz, L D

    • Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes January 1993 42:44-55; doi:10.2337/diabetes.42.1.44

  9. Siddle, K

    • Muscle-specific expression of human insulin receptor in transgenic mice. Diabetes January 1993 42:206-212; doi:10.2337/diabetes.42.1.206

  10. Sima, A A

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

  11. Skoglund, G

    • Galanin-stimulated high-affinity GTPase activity in plasma membranes from RINm5F cells. Diabetes January 1993 42:74-79; doi:10.2337/diabetes.42.1.74

  12. Smerdon, R A

    • Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes January 1993 42:127-133; doi:10.2337/diabetes.42.1.127

  13. Smits, P

    • Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes January 1993 42:148-153; doi:10.2337/diabetes.42.1.148

  14. Sobel, B E

    • Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes January 1993 42:1-7; doi:10.2337/diabetes.42.1.1

  15. Spiro, M J

    • Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes January 1993 42:170-177; doi:10.2337/diabetes.42.1.170

  16. Spiro, R G

    • Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes January 1993 42:170-177; doi:10.2337/diabetes.42.1.170

  17. Steiniger, B

    • The role of histocompatibility antigens in transplantation of isolated islets of Langerhans in the rat. Diabetes January 1993 42:90-97; doi:10.2337/diabetes.42.1.90

  18. Stern, M P

    • Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes January 1993 42:154-161; doi:10.2337/diabetes.42.1.154

  19. Studer, R K

    • Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes January 1993 42:118-126; doi:10.2337/diabetes.42.1.118

T

  1. Thien, T

    • Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes January 1993 42:148-153; doi:10.2337/diabetes.42.1.148

  2. Tilli, P

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

  3. Tobin, B W

    • Insulin secretory function in relation to transplanted islet mass in STZ-induced diabetic rats. Diabetes January 1993 42:98-105; doi:10.2337/diabetes.42.1.98

  4. Turner, R C

    • Distribution of type II diabetes in nuclear families. Diabetes January 1993 42:106-112; doi:10.2337/diabetes.42.1.106
    • Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response. Diabetes January 1993 42:162-169; doi:10.2337/diabetes.42.1.162

U

  1. Uccioli, L

    • Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes. Diabetes January 1993 42:141-147; doi:10.2337/diabetes.42.1.141

V

  1. Valdez, R A

    • Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes January 1993 42:154-161; doi:10.2337/diabetes.42.1.154

  2. Vergani, D

    • Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes January 1993 42:127-133; doi:10.2337/diabetes.42.1.127

  3. Vetri, M

    • Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes January 1993 42:199-205; doi:10.2337/diabetes.42.1.199

  4. Vigneri, R

    • Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes January 1993 42:199-205; doi:10.2337/diabetes.42.1.199

  5. Vinci, C

    • Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes January 1993 42:199-205; doi:10.2337/diabetes.42.1.199

W

  1. Wainscoat, J S

    • Distribution of type II diabetes in nuclear families. Diabetes January 1993 42:106-112; doi:10.2337/diabetes.42.1.106

  2. Watkins, P J

    • Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes January 1993 42:127-133; doi:10.2337/diabetes.42.1.127

  3. Wehrenberg, W B

    • Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes January 1993 42:178-182; doi:10.2337/diabetes.42.1.178

  4. White, J

    • Effects of ethanol on carbohydrate metabolism in the elderly. Diabetes January 1993 42:28-34; doi:10.2337/diabetes.42.1.28

Y

  1. Yarmush, M L

    • Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes January 1993 42:12-21; doi:10.2337/diabetes.42.1.12

Z

  1. Zych, K S

    • Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes January 1993 42:191-198; doi:10.2337/diabetes.42.1.191

Current Issue

  1. November 2009, 58 (11)
    Current Issue
  1. Alert me to new issues of Diabetes